{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:20:16Z","timestamp":1793816416243,"version":"4.6.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/sarh.2001.27736","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"160-175","source":"Crossref","is-referenced-by-count":64,"title":["The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies"],"prefix":"10.1053","volume":"31","author":[{"given":"Ann","family":"VanderBorght","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Raus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Stinissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/sarh.2001.27736_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/bmj.315.7102.236","article-title":"Treatment of rheumatoid arthritis. Science, medicine and future","volume":"315","author":"Buckley","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/sarh.2001.27736_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780380502","article-title":"T-cell receptors in rheumatoid arthritis","volume":"38","author":"Struyk","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2796.1995.tb00923.x","article-title":"Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition","volume":"238","author":"Klareskog","year":"1995","journal-title":"J Int Medicine"},{"key":"10.1053\/sarh.2001.27736_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0925-4439(96)00079-8","article-title":"T-cells in the pathogenesis of rheumatoid arthritis. Villains and accomplices?","volume":"1360","author":"Kinne","year":"1997","journal-title":"Biochem Biophys Acta"},{"key":"10.1053\/sarh.2001.27736_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/292060a0","article-title":"Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein","volume":"292","author":"Ben-Nun","year":"1981","journal-title":"Nature"},{"key":"10.1053\/sarh.2001.27736_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00063.x","article-title":"Therapeutic regulation of T-cells in rheumatoid arthritis","volume":"144","author":"Breedveld","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1053\/sarh.2001.27736_bib7","first-page":"1353","article-title":"V\u03b2 17 T-cell receptor peptide vaccination in rheumatoid arthritis: results of a phase I dose escalation study","volume":"23","author":"Moreland","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4049\/jimmunol.132.2.1031","article-title":"Reduced in vitro immune responses of purified human Leu-3 (helper\/inducer phenotype) cells after total lymphoid irradiation","volume":"132","author":"Field","year":"1984","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.1780240701","article-title":"Lymphapheresis in rheumatoid arthritis: a randomized trial","volume":"24","author":"Karsh","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib10","first-page":"2102","article-title":"Cyclosporin A in rheumatoid arthritis: randomized, placebo controlled dose finding study","volume":"26","author":"Altman","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib11","first-page":"695","article-title":"Cyclosporin A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study","volume":"16","author":"Drosos","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002960050113","article-title":"Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study","volume":"19","author":"Drosos","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1053\/sarh.2001.27736_bib13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780390518","article-title":"Enrichment of differentiated CD45RBdim, CD27-memory T cells in the peripheral blood, synovial fluid and synovial tissue of patients with rheumatoid arthritis","volume":"39","author":"Kohem","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/art.1780351206","article-title":"The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium","volume":"35","author":"Cush","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00271865","article-title":"Pathways of mononuclear infiltration in rheumatoid synovitis","volume":"9","author":"Ziff","year":"1989","journal-title":"Rheumatol Int"},{"key":"10.1053\/sarh.2001.27736_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/00313029309084793","article-title":"Dual CD45RA, CD45RO positive T-lymphocytes within rheumatoid arthritic joints","volume":"25","author":"Hoy","year":"1993","journal-title":"Pathol"},{"key":"10.1053\/sarh.2001.27736_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00831999","article-title":"Antigen-presenting cells in rheumatoid arthritis","volume":"20","author":"Thomas","year":"1998","journal-title":"Springer Semin Immunopathol"},{"key":"10.1053\/sarh.2001.27736_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-3083.1982.tb00729.x","article-title":"In situ characterization of mononuclear cells in rheumatoid arthritis using monoclonal antibodies","volume":"16","author":"Forre","year":"1982","journal-title":"Scand J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-3083.1985.tb01931.x","article-title":"Activated T-lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies","volume":"22","author":"Poulter","year":"1988","journal-title":"Scand J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780310704","article-title":"Elevated soluble interleukin-2 receptor levels in sera and synovial fluid of patients with rheumatoid arthritis","volume":"31","author":"Keystone","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib21","first-page":"63","article-title":"The immunopathogenesis of rheumatoid arthritis","volume":"1","author":"Panayi","year":"1992","journal-title":"Rheumatol Rev"},{"key":"10.1053\/sarh.2001.27736_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780350702","article-title":"The importance of the T-cells in initiating and maintaining the chronic synovitis of rheumatoid arthritis","volume":"35","author":"Panayi","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.1780330602","article-title":"How important are T-cells in chronic rheumatoid synovitis?","volume":"33","author":"Firestein","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0140-6736(93)92627-6","article-title":"Pathogenesis of rheumatoid arthritis","volume":"341","author":"Sewell","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.27736_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/ar115","article-title":"Cell-cell interactions in synovitis: interactions between T lymphocytes and synovial cells","volume":"2","author":"McInnes","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1053\/sarh.2001.27736_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/36.6.617","article-title":"T-cells in rheumatoid arthritis","volume":"36","author":"Breedveld","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.1780400104","article-title":"Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?","volume":"40","author":"Burmester","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0198-8859(93)90507-W","article-title":"T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic rheumatoid arthritis","volume":"37","author":"Struyk","year":"1993","journal-title":"Hum Immunol"},{"key":"10.1053\/sarh.2001.27736_bib29","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/sarh.2001.27736_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/bbrc.1997.7404","article-title":"A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis","volume":"240","author":"Takayanagi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/sarh.2001.27736_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/35005552","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1053\/sarh.2001.27736_bib32","first-page":"475","article-title":"Analysis of T-cell receptor repertoire in rheumatoid arthritis","volume":"15","author":"Borgato","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-1759(98)00201-4","article-title":"Identification of overrepresented TCR genes in blood and tissue biopsies by PCR-ELISA","volume":"223","author":"VanderBorght","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1053\/sarh.2001.27736_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.1857971","article-title":"Evidence for the effect of a superantigen in rheumatoid arthritis","volume":"253","author":"Paliard","year":"1991","journal-title":"Science"},{"key":"10.1053\/sarh.2001.27736_bib35","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1073\/pnas.88.23.10921","article-title":"Limited T-cell receptor \u03b2-chain heterogeneity among interleukin-2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis","volume":"88","author":"Howell","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sarh.2001.27736_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/eji.1830210231","article-title":"Restricted expression of T-cell receptor V\u03b2 but not V\u03b1 genes in rheumatoid arthritis","volume":"21","author":"Sottini","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/39.11.1189","article-title":"Skewed T-cell receptor variable gene in the synovium of rheumatoid arthritis patients: Clonal expansion and persistence of synovial T-cells","volume":"39","author":"VanderBorght","year":"2000","journal-title":"Rheumatol (Oxford)"},{"key":"10.1053\/sarh.2001.27736_bib38","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1172\/JCI117561","article-title":"Dominant clonotypes in the repertoire of peripheral CD4+ T-cells in rheumatoid arthritis","volume":"94","author":"Goronzy","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/sarh.2001.27736_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.57.5.319","article-title":"TCR \u03b2 spectratyping in RA: evidence for clonal expansion in peripheral blood lymphocytes","volume":"57","author":"Hall","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.27736_bib40","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.4049\/jimmunol.161.8.4428","article-title":"Selective accumulation of CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis","volume":"161","author":"Striebich","year":"1998","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib41","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.156.9.3480","article-title":"Persistence of dominant T-cell clones in synovial tissues during rheumatoid arthritis","volume":"156","author":"Alam","year":"1996","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.1780390313","article-title":"Limited heterogeneity of rearranged T-cell receptor V\u03b1 and V\u03b2 transcripts in synovial fluid T-cells in early stages of rheumatoid arthritis","volume":"39","author":"Fischer","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-3083.1992.tb02846.x","article-title":"Characterization of T-cell receptor \u03b1\u03b2 repertoire in synovial tissue from different temporal phases of rheumatoid arthritis","volume":"35","author":"Bucht","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib44","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.4049\/jimmunol.159.10.5143","article-title":"T-cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T-cell expansions","volume":"159","author":"Kato","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0167-5699(93)90163-F","article-title":"Determinant spreading and the dynamics of the autoimmune T-cell repertoire","volume":"14","author":"Lehman","year":"1993","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.27736_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/sarh.2001.27736_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0966-842X(98)01287-6","article-title":"The mimic of molecular mimicry uncovered","volume":"6","author":"Gross","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1053\/sarh.2001.27736_bib48","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/70946","article-title":"Identification of candidate T cell epitopes and molecular mimics in chronic Lyme disease","volume":"5","author":"Hemmer","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/sarh.2001.27736_bib49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"10.1053\/sarh.2001.27736_bib50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/37.6.602","article-title":"A fistful of T-cells","volume":"37","author":"Moots","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-3083.1997.d01-105.x","article-title":"Reactivity patterns of synovial T-cell lines derived from a patient with rheumatoid arthritis. Reactions with defined antigens and auto-antigens suggest the existence of multireactive T-cell clones","volume":"46","author":"Melchers","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0167-5699(98)01283-3","article-title":"Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases?","volume":"19","author":"van den Eden","year":"1998","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.27736_bib53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.1780400616","article-title":"Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis","volume":"40","author":"Verheijden","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1053\/sarh.2001.27736_bib55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/art.1780400317","article-title":"Clonal expansion of mycobacterial heat-shock protein reactive T-lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients","volume":"40","author":"Celis","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08916939709009548","article-title":"Heat shock proteins and arthritis: new readers start here","volume":"26","author":"Gaston","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1053\/sarh.2001.27736_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm0396-306","article-title":"HLA DR4 and HLA DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70kD heat shock proteins","volume":"2","author":"Auger","year":"1996","journal-title":"Nature Med"},{"key":"10.1053\/sarh.2001.27736_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0167-5699(90)90050-J","article-title":"Heat shock proteins and the immune response","volume":"11","author":"Kaufmann","year":"1990","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.27736_bib59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00002281-199106000-00012","article-title":"The immunopathogenesis of rheumatoid arthritis","volume":"3","author":"Firestein","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s001090050217","article-title":"The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease","volume":"76","author":"Cremer","year":"1998","journal-title":"J Mol Med"},{"key":"10.1053\/sarh.2001.27736_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/icb.1997.16","article-title":"Molecular mimicry: Can epitope mimicry induce autoimmune disease?","volume":"75","author":"Davies","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"10.1053\/sarh.2001.27736_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-3083.1988.tb02359.x","article-title":"The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1 and rheumatoid arthritis","volume":"27","author":"Roudier","year":"1988","journal-title":"Scand J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.1780400407","article-title":"Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis","volume":"40","author":"Nakagawa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib64","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1529-0131(199904)42:3<448::AID-ANR9>3.0.CO;2-8","article-title":"Detection of retrovirus 5 in patients with arthritis and systemic lupus erythematosus","volume":"42","author":"Griffiths","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780400206","article-title":"Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity","volume":"40","author":"Tak","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/ar86","article-title":"Macrophages in rheumatoid arthritis","volume":"2","author":"Kinne","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1053\/sarh.2001.27736_bib67","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O","article-title":"Asymptomatic synovitis precedes clinically manifest arthritis","volume":"41","author":"Kraan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib68","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.1780391103","article-title":"Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?","volume":"39","author":"Firestein","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0171-2985(82)80079-X","article-title":"Origin of synovial type A cells during inflammation. An experimental approach","volume":"161","author":"Dreher","year":"1982","journal-title":"Immunobiol"},{"key":"10.1053\/sarh.2001.27736_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/33.9.889-a","article-title":"Simultaneous presentation of rheumatoid arthritis in a sibling pair","volume":"33","author":"McCarthy","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib71","series-title":"Rheumatoid arthritis","author":"Harris","year":"1997"},{"key":"10.1053\/sarh.2001.27736_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780390202","article-title":"Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis","volume":"39","author":"Thomas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0167-5699(96)20030-1","article-title":"Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?","volume":"17","author":"Thomas","year":"1996","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.27736_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.172.1.27","article-title":"The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides","volume":"172","author":"Danska","year":"1990","journal-title":"J Exp Med"},{"issue":"suppl 3","key":"10.1053\/sarh.2001.27736_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1423-0410.1996.tb01378.x","article-title":"Recent advances in HLA","volume":"70","author":"Mayr","year":"1996","journal-title":"Vox Sang"},{"key":"10.1053\/sarh.2001.27736_bib76","first-page":"855","article-title":"Polyarthrite rhumato\u00efde: ses liens avec les molecules HLA DR","volume":"24","author":"Toussirot","year":"1995","journal-title":"La Presse Medicale"},{"key":"10.1053\/sarh.2001.27736_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00831996","article-title":"Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes","volume":"20","author":"Weyand","year":"1998","journal-title":"Springer Semin Immunopathol"},{"key":"10.1053\/sarh.2001.27736_bib78","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1399-0039.1997.tb02905.x","article-title":"The HLA DQ7 and DQ8 associations in DR4 positive rheumatoid arthritis patients","volume":"50","author":"Fugger","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1053\/sarh.2001.27736_bib79","first-page":"1032","article-title":"HLA-DRB1*0401\/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset and disease severity","volume":"22","author":"MacGregor","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/08916939709003856","article-title":"HLA-DR and the development of rheumatoid arthritis","volume":"26","author":"Auger","year":"1997","journal-title":"Autoimmunity"},{"issue":"suppl 44","key":"10.1053\/sarh.2001.27736_bib81","first-page":"5","article-title":"Prognostic implications of HLA genotyping in early assessment of patients with rheumatoid arthritis","volume":"23","author":"Nepom","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib82","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/rheumatology\/36.9.941","article-title":"HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis","volume":"36","author":"Seidl","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib83","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/rheumatology\/35.7.632","article-title":"Polymyalgia rheumatica is associated with both HLA DRB1*0401 and DRB1*0404","volume":"35","author":"Haworth","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib85","first-page":"715","article-title":"Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis","volume":"53","author":"Dizier","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1053\/sarh.2001.27736_bib86","first-page":"335","article-title":"Disease mechanisms in rheumatoid arthritis: gene dosage effect of HLA-DR haplotypes","volume":"124","author":"Weyand","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1053\/sarh.2001.27736_bib87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0198-8859(95)00217-0","article-title":"The role of HLA DR-DR and HLA DR-DP interactions in genetic susceptibility to rheumatoid arthritis","volume":"46","author":"Perdriger","year":"1996","journal-title":"Hum Immunol"},{"key":"10.1053\/sarh.2001.27736_bib88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00002281-199805000-00007","article-title":"The genetic contribution to the pathogenesis of rheumatoid arthritis","volume":"10","author":"Reveille","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009749609082660","article-title":"The role of T-lymphocytes and cytokines in rheumatoid arthritis","volume":"25","author":"Smolen","year":"1996","journal-title":"Scand J Rheumatol"},{"issue":"suppl 1","key":"10.1053\/sarh.2001.27736_bib90","first-page":"23S","article-title":"What is the role of mycloplasmas in human inflammatory rheumatic disorders?","volume":"66","author":"Schaeverbeke","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1053\/sarh.2001.27736_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-9877(98)90103-7","article-title":"The etiology of rheumatoid arthritis","volume":"51","author":"Jefferies","year":"1998","journal-title":"Med Hypotheses"},{"key":"10.1053\/sarh.2001.27736_bib92","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","article-title":"Rheumatoid arthritis: Pathophysiology and implications for therapy","volume":"322","author":"Harris","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.27736_bib93","first-page":"53","article-title":"Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in the joints of DBA\/1 mice immunized with type II collagen","volume":"58","author":"Holmdahl","year":"1988","journal-title":"Lab Invest"},{"key":"10.1053\/sarh.2001.27736_bib94","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/ard.51.7.919","article-title":"Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications","volume":"51","author":"Colville-Nash","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.27736_bib95","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/38.3.214","article-title":"Quantitation of interferon gamma- and interleukin-4\u2013producing T cells in synovial fluid and peripheral blood of arthritis patients","volume":"38","author":"van der Graaff","year":"1999","journal-title":"Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0167-5699(97)01087-6","article-title":"Seeing the woods for the trees: the forgotten role of neutrophils in rheumatoid arthritis","volume":"19","author":"Edwards","year":"1997","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.27736_bib97","first-page":"136","article-title":"The role of cytokines and growth factors in cartilage destruction of osteoarthritis and rheumatoid arthritis","volume":"58","author":"van den Berg","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib98","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/ard.57.8.480","article-title":"A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers","volume":"57","author":"Elewaut","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.27736_bib99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci"},{"issue":"suppl 2","key":"10.1053\/sarh.2001.27736_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.87","article-title":"Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?","volume":"34","author":"Emery","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"suppl 18","key":"10.1053\/sarh.2001.27736_bib101","first-page":"S59","article-title":"Combination DMARD therapy including corticosteroids in early rheumatoid arthritis","volume":"6","author":"Mottonen","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib102","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.59.6.468","article-title":"Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands","volume":"59","author":"van Jaarsveld","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"suppl 112","key":"10.1053\/sarh.2001.27736_bib103","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/030097499750042236","article-title":"Disease modification in rheumatoid arthritis with leflunomide","author":"Emery","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib104","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02215854","article-title":"Mechanism of action of cyclosporin in rheumatoid arthritis","volume":"14","author":"Bentin","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"suppl 3","key":"10.1053\/sarh.2001.27736_bib105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0049-0172(92)90009-3","article-title":"Mechanisms of action of cyclosporin and effects on connective tissues","volume":"21","author":"Russel","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib106","first-page":"1457","article-title":"A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis","volume":"25","author":"Wendling","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib107","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.1780380812","article-title":"A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis","volume":"38","author":"van der Lubbe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib108","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/art.1780381109","article-title":"Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate","volume":"38","author":"Moreland","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib109","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.51.1.207","article-title":"Anti-cytokine therapy for rheumatoid arthritis","volume":"51","author":"Maini","year":"2000","journal-title":"Ann Rev Med"},{"key":"10.1053\/sarh.2001.27736_bib110","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib111","first-page":"S224","article-title":"Interleukin-1 receptor antagonist continues to demonstrate clinical improvement in rheumatoid arthritis","volume":"40","author":"Nuki","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib112","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(94)90632-7","article-title":"Repeated therapy with monoclonal antibody to tumor necrosis factor a (cA2) in patients with rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.27736_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib114","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1357-4310(00)01757-3","article-title":"Cytokines in rheumatoid arthritis: trials and tribulations","volume":"6","author":"Carteron","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1053\/sarh.2001.27736_bib115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/rheumatology\/34.4.334","article-title":"The therapeutic effects of an engineered human anti-tumor necrosis factor antibody (CDP571) in rheumatoid arthritis","volume":"34","author":"Rankin","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.27736_bib116","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor-\u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib117","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/sarh.2001.27736_bib118","first-page":"170","article-title":"Preliminary results of early clinical trials with fully human anti-TNF monoclonal antibody D2E7","volume":"58","author":"Kempeni","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sarh.2001.27736_bib119","first-page":"57","article-title":"A single dose placebo-controlled phase I study of the fully human anti-TNF antibody D2E7 in patients with rheumatoid arthritis","volume":"41","author":"van de Putte","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib120","first-page":"55","article-title":"Long term efficacy and tolerability of multiple doses of the fully human anti-TNF antibody D2E7 in patients with rheumatoid arthritis","volume":"41","author":"Rau","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib121","first-page":"57","article-title":"Efficacy and tolerability of weekly subcutaneous injections of the fully human anti-TNF antibody D2E7 in patients with rheumatoid arthritis","volume":"41","author":"Schattenkircher","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib122","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.27736_bib123","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of Etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.27736_bib124","first-page":"1950","article-title":"Sustained improvement in rheumatoid arthritis following B lymphocyte depletion","volume":"43","author":"Edwards","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/135245859800400322","article-title":"Myelin reactive T-cells in the autoimmune pathogenesis of multiple sclerosis","volume":"4","author":"Stinissen","year":"1998","journal-title":"Mult Scler"},{"key":"10.1053\/sarh.2001.27736_bib126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1615\/CritRevImmunol.v17.i1.20","article-title":"Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies","volume":"17","author":"Stinissen","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1053\/sarh.2001.27736_bib127","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.7690157","article-title":"MHC restricted clonotypic depletion of human myelin basic protein-reactive T-cells by T-cell vaccination","volume":"261","author":"Zhang","year":"1993","journal-title":"Science"},{"key":"10.1053\/sarh.2001.27736_bib128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(95)91622-9","article-title":"Depletion of myelin-basic-protein autoreactive T-cells by T-cell vaccination: pilot trial in multiple sclerosis","volume":"346","author":"Medaer","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/sarh.2001.27736_bib129","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1529-0131(199811)41:11<1919::AID-ART5>3.0.CO;2-1","article-title":"T-cell receptor peptide vaccination in rheumatoid arthritis. A placebo controlled trial using a combination of BV3, BV14 and BV17 peptides","volume":"41","author":"Moreland","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-857X(05)70031-4","article-title":"T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis","volume":"24","author":"Bridges","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/sarh.2001.27736_bib131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/oxfordjournals.bmb.a072976","article-title":"Gene therapy of rheumatoid arthritis via cytokine regulation: future and perspectives","volume":"51","author":"Chernajovsky","year":"1995","journal-title":"Br Med Bull"},{"key":"10.1053\/sarh.2001.27736_bib132","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.158.7.3492","article-title":"Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective","volume":"158","author":"Muller-Ladner","year":"1997","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib133","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.4049\/jimmunol.156.9.3558","article-title":"Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy","volume":"156","author":"Otani","year":"1996","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.27736_bib134","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00832007","article-title":"Gene therapy for rheumatoid arthritis","volume":"20","author":"Robbins","year":"1998","journal-title":"Springer Semin Immunopathol"},{"key":"10.1053\/sarh.2001.27736_bib135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.27736_bib136","first-page":"529","article-title":"Treatment of autoimmune diseases through manipulation of antigen presentation","volume":"17","author":"Spack","year":"1997","journal-title":"Crit Rev Immunol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901720168380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901720168380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:49:54Z","timestamp":1682138994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901720168380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S004901720168380X"],"URL":"https:\/\/doi.org\/10.1053\/sarh.2001.27736","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}